Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.81 in the last session, down -3.32% from day before closing price of $0.84. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 0.77 million shares were traded. MCRB stock price reached its highest trading level at $0.858 during the session, while it also had its lowest trading level at $0.803.
Ratios:
We take a closer look at MCRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when DesRosier Thomas sold 878 shares for $0.54 per share. The transaction valued at 475 led to the insider holds 135,192 shares of the business.
von Moltke Lisa sold 977 shares of MCRB for $528 on Nov 18 ’24. The insider now owns 32,415 shares after completing the transaction at $0.54 per share. On Nov 18 ’24, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 2,505 shares for $0.54 each. As a result, the insider received 1,355 and left with 170,389 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 138929520 and an Enterprise Value of 136671248. For the stock, the TTM Price-to-Sale (P/S) ratio is 2315.44 while its Price-to-Book (P/B) ratio in mrq is 5.79. Its current Enterprise Value per Revenue stands at 1.082 whereas that against EBITDA is -3.745.
Stock Price History:
The Beta on a monthly basis for MCRB is 2.10, which has changed by -0.25486726 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, MCRB has reached a high of $1.53, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -2.35%, while the 200-Day Moving Average is calculated to be -8.41%.
Shares Statistics:
According to the various share statistics, MCRB traded on average about 2.83M shares per day over the past 3-months and 3442750 shares per day over the past 10 days. A total of 170.20M shares are outstanding, with a floating share count of 124.81M. Insiders hold about 26.90% of the company’s shares, while institutions hold 23.56% stake in the company. Shares short for MCRB as of 1736899200 were 20261193 with a Short Ratio of 7.16, compared to 1734048000 on 19613483. Therefore, it implies a Short% of Shares Outstanding of 20261193 and a Short% of Float of 15.879999999999999.
